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Light dispersionis derived from the amino acid sequence of the Cry11Bb1 protoxin, is able to
permeabilize mitochondrial membranes and reveals antimicrobial activity. In this work we demonstrated
that the permeabilizing activity of BTM-P1 for the plasma membrane of rat red blood cells increased in a
dose-dependent manner for the concentration range of 1–4 μg/ml. Using osmotic protectants, the radius of
pores formed at 4 μg/ml BTM-P1 was determined as 0.8 nm for 5 min hemolysis data, 0.7 nm for 5 min
decrease in light dispersion of the cell suspension and 0.5 nm for the light dispersion slope measurements.
The permeabilizing activity of 1 μg/ml peptide was increased by valinomycin-induced plasma membrane
potential, especially under moderately hypotonic conditions. These results might explain the antimicrobial
activity of BTM-P1 and support the hypothesis of potential-dependent and pro-apoptotic character of toxicity
of naturally proteolysed Cry11Bb1 protoxin for epithelial cells of mosquito larvae midgut.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
The polycation peptides form part of the host defense system of
many organisms, including insects, plants, and animals [1,2]. Most of
them demonstrate activity against bacteria, fungi and protozoa [2–5].
The increasing number of pathogenic organisms with resistance to
conventional antibiotics has raised interest in applications of
antimicrobial peptides to treat infections [6]. There are several
polycation peptides that are currently being investigated for this
pharmaceutical propose [7–9].
The design of synthetic amphipathic peptides based on known
structures of discovered natural peptides with antimicrobial activity
has a great potential in order to improve the efﬁcacy and selectivity of
their action [10]. Some peptides of the same class have shown
promising antitumor activity [11]. The polycation peptides such as
mastoparan [12] or BMAP-28 [13], for example, have been shown to
permeabilize mitochondrial membranes suggesting a possible
mechanism of pro-apoptotic and pro-necrotic actions in eukaryotic
cells.
The pore-forming protein toxins were found not only in eukaryotic,
but also in prokaryotic cells [14]. The bacterial protein toxins have
received far more attention than those from any other kind of
organism, as a concern for their disease-causing abilities and for
possible practical applications [15]. Bacillus thuringiensis serovar. me-4 2604489.
).
ll rights reserved.dellin, for example, produces the protoxin Cry11Bb1 (94 kDa), which
reveals toxic effects against different species of mosquito larvae like
Culex quinquefasciatus and Aedes aegypti [16]. The action of
Cry11Bb1 is dependent of the solubilization and a proteolytic
processing in the midgut of the susceptible larvae, where shorter
segments of the protein are produced. At least two different fragments
of Cry11Bb1 (30 and 35 kDa), to which the toxic effect could be
attributed, are generated by the proteolysis [17]. The possibility that
shorter fragments with membrane permeabilizing activity could be
generated during Cry11Bb1 proteolysis has not been reported in the
literature.
Based on the amino acid sequence of the domain I of the Cry11Bb1
protoxin, we recently designed a novel polycation peptide, BTM-P1,
composed of 26 amino acid residues [18–20]. This polycation fragment
is sufﬁciently long to traverse a membrane. It contains 4 hydrophobic
amino acid residues at the N-terminus, which should facilitate the
incorporation of the peptide into a lipid bilayer, and 22 amino acid
residues of the domain I α2 helix. Three lysine residues and one
hydroxyl-containing threonine, each in the i+4 position of the α2a
helix [21], should be important for forming an amphipathic helix with
an aligned polar side and an opposing, relatively hydrophobic side.
The presence of a double AXXXAmotif (AXXXAXXXA) in theα2a helix
sequence could be favorable for peptide oligomerization in a lipid
environment [22,23], allowing membrane permeabilization as was
suggested earlier [19]. The possibility of formation of typical helical
structure in BTM-P1 between residues K6-A22 was demonstrated by
1H NMR [20]. In addition, a 68% helical structure of the peptide was
Fig. 1. Swelling and hemolysis of rat RBC induced by the peptide BTM-P1. RBC were
incubated in isotonic medium (150 mM NaCl, 5 mM Tris–HCl, pH 7,4) at 0.17%
hematocrit; P–the addition of the peptide at concentrations of 1 (b), 2 (c), 3 (d) and 4 (e)
μg/ml; T–the addition of 0.01% Triton X-100 (f); a–control without any addition. The
numbers at the end of the curves represent hemolysis evaluated at the end of each
incubation, means±SEM (n=3).
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[20]. These data supported the hypothesis that BTM-P1 forms ion
channels due to its transmembrane oligomerization [19,20]. The
particular mechanism, “barrel-stave” or “toroidal pore” [24 and
references therein], or a clustering of membrane negatively charged
lipids by polycation peptides [25], has not yet been established.
BTM-P1 has been shown to induce mitochondrial swelling and to
cause uncoupling of the oxidative phosphorylation system [19]. It also
demonstrated high activity against Gram-positive and Gram-negative
bacteria [18,20]. Except for an evaluation of hemolysis [20], its
capacity to permeabilize the plasma membrane of eukaryotic cells
has not yet been studied in detail and it seems to be important to
investigate the mechanism of toxicity of Cry protoxins.
In this work we studied permeabilization of the plasma
membrane of rat red blood cells (RBC) by the peptide BTM-P1. On
the basis of measurements of hemolysis and light dispersion of cell
suspensions versus molecular mass of mannitol, sucrose and
polyethylene glycols, used as osmotic protectants, the radius of
membrane pores formed by this peptide was determined to be in the
range of 0.5–0.8 nm. Valinomycin-induced membrane potential of
relatively high magnitude (negative inside) essentially increased the
capacity of BTM-P1 to permeabilize the plasma membrane of RBC
that was in concordance with the earlier suggested potential-
dependent mechanism of permeabilization of the inner mitochon-
drial membrane by this peptide [19]. The data obtained are in favor of
a potential-dependent and apoptosis-like mechanism of toxicity of
the naturally proteolysed Cry11Bb1 protoxin for epithelial cells of
mosquito larvae midgut.
2. Material and methods
2.1. Materials
Most of the chemicals of analytical grade were purchased from
Sigma Chemical Co. (St. Louis, MO, USA), valinomycin was from
Merck and polyethylene glycols of highest purity were from FLUKA.
The peptide BTM-P1 was synthesized by Fundación Instituto de
Inmunología de Colombia (Bogota, Colombia) by the solid phase
method [26], according to the amino acid sequences proposed by
some of the authors of this work. A p-methyl benzhydrylamine-resin
(0.7 Meq/g), t-Boc amino acids (Bachem, USA) and low-high
cleavages were used in the process [27]. The peptide was puriﬁed
by high-pressure liquid chromatography, analyzed by mass spectro-
metry (Maldi-Tof), lyophilized and kept as a powder and as a water
solution at 4 °C before use.
2.2. Isolation of red blood cells
RBC were obtained as described in [28] with slight modiﬁcation.
Approximately 5 ml of Sprague/Dawley rat blood was diluted in 20 ml
of medium composed of 120 mM NaCl, 10 mM EDTA, 5 mM sodium
citrate and 5 mM Tris–HCl, pH 7.4, and centrifuged at 3000 rpm for
10min at 15 °C. The pellet was washed twice by gentle resuspension in
20 ml of 150 mM NaCl and 5 mM Tris–HCl, pH 7.4, and subsequent
centrifugation at 3000 rpm for 10 min at 15 °C. The ﬁnal pellet was
resuspended in the same medium supplemented with 10 mM glucose
to a ﬁnal hematocrit of 20%.
2.3. Monitoring of plasma membrane permeabilization
The plasma membrane permeabilization accompanied with RBC
swelling and light dispersion changes of cell suspension was
monitored by measuring the apparent light absorbance at 640 nm
(A640) using a Spectronic Genesys-2 spectrophotometer under con-
stant stirring at 25 °C. RBC were added to 1.2 ml of isotonic medium
(150 mM NaCl, 5 mM Tris–HCl, pH 7.4) or to 1.2 ml of approximatelysemi-isotonic medium (85 mM NaCl, 5 mM Tris–HCl, pH 7.4) to a ﬁnal
hematocrit of 0.17%. The BTM-P1 was added at the concentrations of
1–4 μg/ml. To evaluate the inﬂuence of the moderately hypotonic
conditions and/or the membrane potential on the permeabilizing
activity of BTM-P1, the above mentioned isotonic and semi-isotonic
media were supplemented with 0.1 mM KCl and 0.5 μM valinomycin.
After incubation of the rat RBC with the peptide for 2 or 3 min,
hemolysis was evaluated by measuring light absorbance at 541 nm
(A541) in the supernatants obtained by centrifugation of samples at
13000×g for 2 min at 15 °C. Hemolysis determined in the presence of
0.01% Triton X-100 was taken as 100%.
2.4. Pore size estimation
The size of pores formed by BTM-P1 in the plasma membrane was
estimated on the basis of hemolysis and light dispersion changes of
RBC suspensions caused by the peptide in incubation media contain-
ing 135 mM NaCl, 5 mM Tris–HCl, pH 7.4, supplemented with osmotic
protectants such as mannitol, sucrose, PEG-600, PEG-1000, PEG-1500,
PEG-2000 and PEG-3000 at the concentration of 30 mM. RBC were
added to a ﬁnal hematocrit of 0.17%. After 5 min of incubationwith the
4 μg/ml BTM-P1, the extent of permeabilization was evaluated by
hemolysis and by A640 change of the cell suspensions, as well as by
determining of the A640 slope using a Spectronic Genesys-2 spectro-
photometer. The effects caused by the peptide in 150 mM NaCl, 5 mM
Tris–HCl, pH 7.4, in the absence of osmotic protectants were taken
equal to 100%.
3. Results
3.1. Plasma membrane permeabilization by BTM-P1
The measure of light dispersion of the rat RBC suspensions as
apparent absorbance A640 before and after the addition of 1 μg/ml
(Fig. 1, b), 2 μg/ml (Fig. 1, c), 3 μg/ml (Fig. 1, d) and 4 μg/ml (Fig. 1, e) of
BTM-P1 allowed the observation of a dose-dependent permeabiliza-
tion of the plasma membrane in isotonic NaCl-Tris media in a scale
between the control (without the peptide) (Fig. 1, a) and complete
hemolysis caused by 0.01% Triton X-100 (Fig. 1, f). Light dispersion
data were in concordance with hemolysis determined at the end of
the 2 min period of incubation with the peptide (Fig. 1, numbers at
the end of the curves). The correlation coefﬁcient between these
parameters was equal to 0.97. Complete cell swelling was developed
in approximately 1 min after the addition of the peptide at 2–4 μg/ml
(Fig. 1, c–e). No detectable cell swelling was registered when only
1 μg/ml of BTM-P1 was added to the RBC suspension in isotonic NaCl-
Tris medium (Fig. 2A, a). A similar result was observed for moderately
hypotonic conditions, when the incubation medium contained
85 mM NaCl, 0.1 mM KCl and 5 mM Tris–HCl (Fig. 2A, b).
Fig. 2. Inﬂuence of osmotic pressure of incubation medium and of membrane potential
on the swelling of rat RBC induced by the peptide BTM-P1. RBC were added to isotonic
(150 mM NaCl, 5 mM Tris–HCl, 0.1 mM KCl, pH 7.4) (a), or semi-isotonic (85 mM NaCl,
5 mM Tris, 0.1 mM KCl, pH 7.4) (b) incubation media at 0.17% hematocrit without (A) or
with (B) 0.5 μM valinomycin. P–1 μg/ml BTM-P1. The inset ﬁgure in panel B represents
hemolysis determined at the end of RBC incubation with the peptide in isotonic (c) and
semi-isotonic (d) media containing 0.5 μM valinomycin. The numbers at curves
represent A640 data at the end of each incubation, means±SEM (n=3).
Fig. 3. Evaluation of the size of pores formed by BTM-P1 in the plasma membrane of rat
RBC. Panel A: light dispersion changes registered as A640 of RBC suspensions of 0.17%
hematocrit in 150 mMNaCl and 5 mM Tris–HCl (a, i) or in 135mMNaCl and 5 mM Tris–
HCl supplemented with 30 mM mannitol (b), sucrose (c), PEG-600 (d), PEG-1000 (e),
PEG-1500 (f), PEG-2000 (g) or PEG-3000 (h) as osmotic protectants; P–the addition of
4 μg/ml BTM-P1 (b–i); i–control without osmotic protectants; a–non-treated control,
without any addition. Panel B: the effect of osmotic protectants on hemolysis (a) and
A640 changes (b) determined after 5 min incubation of RBC with the peptide, as well as
on the A640 slope. Panel C: correlation between hemolysis and A640 changes according
to the data presented in panel B (a and b, respectively). The data aremeans±SEM (n=3).
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of BTM-P1 in rat liver mitochondria was strongly increased by the
innermembrane potential [19]. The membrane potential of normal rat
RBC is known to be about −10 mV [29]. In order to test if the artiﬁcial
increase in the plasma membrane potential might enhance the
permeabilizing activity of BTM-P1, 0.5 μM valinomycin was added to
the cell suspension before adding the peptide. The addition of
valinomycin caused initial shrinkage of RBC that was observed as an
increase in A640 (Fig. 2B, a, b), probably due to the efﬂux of potassium
ions accompanied with a slow release of chloride anions. Valinomycin
also increased the permeabilizing activity of subsequently added 1 μg/
ml BTM-P1 that was expressed as cell swelling in isotonic (Fig. 2B, a)
or in moderately hypotonic (Fig. 2B, b) media containing 0.1 mM KCl,
as well as in a more signiﬁcant hemolysis that was higher in
moderately hypotonic (Fig. 2B, d) than in isotonic (Fig. 2B, c) media.
These results showed a meaningful synergistic effect of the plasma
membrane permeabilization by BTM-P1 caused by valinomycin and
moderately hypotonic conditions, thus leading to almost complete
hemolysis (Fig. 2B, d) and to a signiﬁcant decrease in A640 of the cell
suspension (Fig. 2B, b).
3.2. Pore size estimation
To estimate the size of pores formed by BTM-P1 in the plasma
membrane of normal rat RBC, we ﬁrst determined the dependence of
light dispersion decrease and of hemolysis, induced by the peptide, on
the molecular weight of osmotic protectants included in isoosmotic
incubation media at 30 mM concentration. Mannitol (Fig. 3A, b),
sucrose (Fig. 3A, c), PEG-600 (Fig. 3A, d), PEG-1000 (Fig. 3A, e), PEG-
1500 (Fig. 3A, f), PEG-2000 (Fig. 3A, g) and PEG-3000 (Fig. 3A, h) were
used as osmotic protectants. The data obtained were normalizedtaking as 100% the effects caused by RBC treatment with 4 μg/ml BTM-
P1 without osmotic protectants (Fig. 3A, i; Fig. 3B, control) and as 0%
for the non-treated control (without the peptide and osmotic
protectants). As shown in Fig. 3A, curve a, no light dispersion decrease
was observed for the non-treated control. Taking into account the
known hydrodynamic radii of used osmotic protectants [30] and
estimating the molecular weight of osmotic protectant that should
cause a 50% decrease in A640 drop for the cell suspension (Fig. 3B, b) or
a 50% decrease of hemolysis (Fig. 3B, a), the pore radius was
determined as approximately 0.7 nm and 0.8 nm, respectively, for
5 min incubation of the rat RBC with 4 μg/ml BTM-P1. An excellent
correlation (r2=0.98) was obtained between hemolysis and A640 data
(Fig. 3C), indicating that the pore size measured by the two different
approaches were the same. A smaller pore radius (0.5 nm) was
determined according to the 50% decrease in the A640 slope (Fig. 3B, c).
Fig. 4. Helical wheel projection (A) and toroidal-like pore model (B) proposed for BTM-
P1. Panel A: Helical wheel projection of α2a helix using the one letter code; the
hydrophobic residues are presented in white, polar residues in gray and highly polar
cationic residues in black circles in the wheel. The N-term and C-term regions of BTM-
P1, which are not part of the α2a helix, are presented as ﬂexible sequences at the
beginning and the end of the α2a helix, respectively. The hydrophobic moment (μH) of
the α2a helix was calculated on the basis of consensus scale of hydrophobicity [47].
Panel B: The N-term VAPI region is embedded into the hydrophobic core of the
membrane and the cationic residues (+) of the C-term FAKLKS region and of the α2a
helix are interacting with negative head groups of phospholipids thus forming toroidal-
like pores.
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To explain the mode of action of Cry toxins produced by B.
thuringiensis, three hypotheses have been proposed [31]. The ﬁrst one
indicates that the Cry toxins recognize a receptor in the apical
microvilli of the midgut of susceptible insects and insert in the cell
membrane thus causing formation of pores and cell death by osmotic
unbalance [32,33]. A second proposal indicates that in addition to pore
formation and osmotic unbalance, bacteria from the midgut micro-
ﬂora are necessary to produce septicemia and insect death [34]. The
third hypothesis suggests the activation of intracellular signals
mediated by the interaction of the Cry toxins with a receptor [35].
The segment of the Cry proteins responsible for membrane
permeabilization is Domain I composed of seven α helices [36].
Gerber and Shai [37] have found that the α4–α5 hairpin of the Cry1Ac
toxin is the membrane inserted region in which both helices line the
lumen of the pore. In addition, Leetachewa et al. [38] have
demonstrated that a hairpin formed by the α4–α5 helices of the
Cry4B toxin is active in permeabilization of unilamellar liposomes.
Puntheeranurak et al. [39] have observed that the α1–α5 fragment of
the Cry4B toxin induces the formation of cation selective pores in
planar lipid bilayers suggesting that this fragment can form functional
channels.
Some insecticidal B. thuringiensis strains display antimicrobial
activity after their Cry proteins are proteolytically cleaved [40], and
some non-insecticidal B. thuringiensis strains produce a new class of
crystal proteins, parasporins, which are active against a number of
cancer cell lines after proteolysis [41,42]. Recently, we have demon-
strated that a 26 amino acid residue peptide BTM-P1, derived from the
primary structure of the Cry11Bb1 protoxin of B. thuringiensis serovar.
medellin (BTM-P1) [18,19], adopts a three-dimensional structure as an
α-helix [20] and displays antibacterial activity against Gram negative
and Gram positive bacteria [18,20]. It can permeabilize rat liver
mitochondria [19] at concentrations lower than mastoparan [12].
In this work, we studied the capability of BTM-P1 to permeabilize
the plasma membrane of rat RBC. The obtained results show that the
peptide induces swelling and hemolysis of RBC at concentrations
higher than 1 μg/ml (Fig. 1). The radius of pores formed at 4 μg/ml
BTM-P1 and estimated using 30 mM osmotic protectants was
approximately 0.7–0.8 nm according to the light dispersion and
hemolysis data and 0.5 nm according to the A640 slope changes (Fig.
3B). These values of pore size are lower than the hydrodynamic
radius of PEG-1000 and thus cannot be affected by hemoglobin
precipitation caused by 30 mM PEGs of molecular weight higher than
3000 (for details see [43]). The determined pore size of 0.5–0.8 nm is
very close to the pore sizes reported for other antimicrobial peptides
with similar lengths. For comparison, the magainins, 23-residue
peptides with charge of +4 (Table 1) from the skin of the Xenopus
laevis frog, form pores or structural defects of approximately 1 nm in
diameter in both, liposomes and mitochondrial inner membrane [44].
The peptide melittin, isolated from the honey bee venom (Apis
mellifera), formed by 26 amino acid residues with a net charge of +6
(Table 1) [45], generates pores with radius of 0.63–0.67 nm in
liposomes [46].Table 1
Physicochemical parameters of BTM-P1 and representative antimicrobial peptides
Peptide Origin Amino acid s
BTM-P1 B.thuringiensis VAPIAKYLATA
α2a helix [21] B.thuringiensis AKYLATALAK
Magainin 1 [44] X. laevis GIGKFLHSAG
Magainin 2 [44,48] X. laevis GIGKFLHSAK
Melittin [45,48] Apis mellifera GIGAVLKVLTT
⁎ Mean hydrophobic moment (μH) calculated according to the consensus scale of hydro
1–21) [48].As a working hypothesis, we assume that highly hydrophobic N-
term region (VAPI) of BTM-P1 could function as an anchor facilitating
the incorporation of an amphipathic α2a helix (Fig. 4A) into the
hydrophobic core of the membrane as shown in Fig. 4B. The
hydrophobic moment of BTM-P1 is equal to 0.098 (Table 1) calculated
using the consensus scale of Eisenberg [47] and considering the entire
peptide as the alpha helix. On the other hand, the hydrophobic
moment of BTM-P1 α2a helix is higher and is equal to 0.186 (Table 1,
Fig. 4A) that is somewhat less than those calculated by the same
method for melittin and magainins (Table 1) [48]. The relatively
hydrophilic C-term region (FAKLKS) of the BTM-P1 (Fig 4A) might
function as a polar anchor interacting with negatively charged
phospholipids of the outer leaﬂet of the lipid bilayer (Fig 4B). It is
very probable that BTM-P1 forms “toroidal pores”, as was suggested
for magainins and melittin [44,45 and references therein], taking into
account the similarity of the length, charge and α-helix structure in
hydrophobic environment for these peptides [44,48] and BTM-P1 [20]
(Table 1), as well as the similarity of pore sizes [44,46] (Fig. 3B). The
mechanism of membrane permeabilization by BTM-P1 could be alsoequence Net charge μH⁎
LAKWALKQGFAKLKS 5+ 0.098
WALKQG 3+ 0.186
KFGKAFVGEIMKS 4+ 0.310
KFGKAFVGEIMNS 4+ 0.286
GLPALISWIKRKRQQ-NH2 6+ 0.266
phobicity [47]. The melittin μH was calculated for the α-helical region only (residues
Fig. 5. “Damaged umbrella oligomerization” model of the membrane permeabilization
by activated Cry11Bb1 domain I. Panel A: Theα2a helix is embedded into themembrane
in addition to the α4 and α5 helices, as a modiﬁcation of the model of Gazit et al. [54].
Panel B: Hypothetic scheme of formation of “damaged umbrella” oligomers that might
be tetramers [55].
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polycation peptides [25], or with initial formation of transitional
disordered torodial-like pores proposed for magainin-2 and melittin
[49,50], ﬁnally leading to the formation of barrel-stave or toroidal
pores as it was suggested by Sengupta et al. [50].
The permeabilizing activity of BTM-P1 was essentially increased by
artiﬁcially generated high plasma membrane potential in rat RBC (Fig.
2B). These results are in agreement with those indicating that the
permeabilizing activity of BTM-P1 is highly expressed in the energized
but not in the de-energized rat liver mitochondria [19]. It seems to be
very probable that the electrical potential of the plasma membrane of
epithelial cells promotes transmembrane movement of positively
charged oligomers of the peptides like BTM-P1 inside the cells, which
could reachmitochondria and causemitochondrial membrane permea-
bilization. This concept is consistent with the relatively high transe-
pithelial potential found in the posterior region of larval Aedes aegypti
midgut, which is lumen positive in contrast to the lumen negative
potential of the anterior “stomach” region [51]. Hyperpolarization of the
apical membrane of the posterior larval midgut (negative potential
inside the epithelial cells) is attributed to the H+ V-ATPase, which
appears to be localized therein and expels protons from the cells [52 and
references therein]. This negative potentialmight increase the toxicity of
membrane active polycationpeptides for theposterior “stomach” region
of A. aegypti larvae. This assumption is in accordancewith experimental
data showing that the lesion caused by the Cry11Bb1 toxin is most
prominent for epithelial cells of the posterior larval midgut [53].
The data obtained in this work support the “damaged umbrella
oligomerization” model of permeabilization of the midgut epithelial
cells by Cry proteins [19] (Fig. 5). Initially, the “umbrella model”
considered the formation of pores by the oligomerization of domain I
of the Cry family proteins, where α4 and α5 helices are the only ones
inserted into the membrane and the remaining helices lie on the
membrane surface [54]. The high membrane permeabilizing activity
of BTM-P1, which contains signiﬁcant part of the α2 helix, allows thesuggestion that the α2a helix of Cry11Bb1 is also inserted in the
membrane, in addition to theα4 andα5 helices (Fig. 5A), thus forming
oligomers of “damaged umbrellas” that might be tetramers [55] as
shown in Fig. 5B. This hypothesis is consistent with recent data
obtained for other Cry toxins indicating that the α1 is the only α helix
of domain I from Cry1Ab that is not inserted in the membrane [56], or
that the α2 and α3 helices of the trypsin activated Cry1Aa protein
might be either embedded in or strongly interacting with the brush
border membrane [57].
The proteolytic processing of Cry11Bb1 protoxin might result in
other α2 helix fragments or in larger fragments containing BTM-P1 as
their part, which also possess membrane permeabilizing activity [58].
The pore size determined for the plasma membrane permeabilization
by BTM-P1 is large enough for the phosphonucleotides to diffuse out
of the cell. This fact allows speculation that cytosolic ATP, ADP and
mitochondrial energetic substrates can be lost resulting in a decreased
ability of mitochondria to maintain an effective oxidative phosphor-
ylation process in addition to the possibility that the peptides can
directly permeabilize mitochondrial membranes [19] thus inducing
apoptosis of epithelial cells of the larval A. aegypti posterior midgut.
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